Pons-Estel, B.A., Catoggio, L.J., Cardiel, M.H., Soriano, E.R., Gentiletti, S., Villa, A.R., Abadi, I., Caeiro, F., Alvarellos, A. and Alarcón-Segovia, D. (2004) Grupo latinoamericano de estudio del lupus. The GLADEL multinational Latin American prospective inception cohort of 1,214 patients with systemic lupus erythe- matosus: Ethnic and disease heterogeneity among ‘His- panics’, Medicine (Baltimore), 83(1), 1-17.

has been cited by the following article:

• TITLE: Histone H1/MBP hydrolysing antibodies - novel potential marker in diagnosis of disease severity in systematic lupus erythematosus patients

  AUTHORS: Valentyna Chopyak, Yaroslav Tolstiak, Iryna Magoryvska, Rostyslav Bilyy, Rostyslav Bilyy, Natalya Korniy, Yuriy Kit, Rostyslav Stoika

  KEYWORDS: System Lupus Erythematosus; Proteolytic Activity; IgG-Antibodies; Disease Severity

  JOURNAL NAME: Health, Vol.2 No.10, October 26, 2010

  ABSTRACT: Recently we have shown the presence of catalytically active IgGs, capable to cleave histone H1 and bovine myelin basic protein (MBP), in blood serum of SLE patients. Here we present data that demonstrate the correlation between a) proteolytic activity towards histone H1 and MBP of IgG-antibodies from blood serum of SLE patients and b) disease severity level in these patients. IgGs were isolated from blood serum by chromatography on protein G-sepharose. Commercial preparations of bovine myelin basic proteins (MBP) and calf thymus histone H1 were used as substrates. Analysis of the proteolytic activity showed that 16 of 38 lgG-preparations (42,1%) obtained from blood serum of SLE patients were capable of cleaving both histone H1 and MBP with different efficiency. It was revealed that the presence in blood serum of lgGs possessing proteolytic activity towards both histone H1 and bMBP closely correlates with manifestation of the disease severity in SLE patients.